Siegfried Holding AG

SFZN: XSWX (CHE)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|!<LOCK|%PXZ^LOCK|lK$Y$%

Siegfried: Dinamiqs Facility Strengthens Manufacturing Capabilities; Healthy Outlook for 2026

Siegfried continues to strengthen its manufacturing capabilities in the rapidly growing cell and gene therapy market. Its completed facility, Dinamiqs, enables end-to-end manufacturing of viral vector gene therapies from molecule design to aseptic drug product filling.

Sponsor Center